Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Track expenses and income using a simple framework to gain clarity on where your money goes and how your finances fit together.
28,655 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
The CLARITY Act faces a daunting 60-vote hurdle in the Senate, with July hearings and a looming August recess narrowi...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
A brutal four-session selloff in Korea’s chip sector erased roughly $900 billion in market value, even as analysts in...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
Savers face a fast-moving market where finding best high-yield savings requires careful rate shopping. This report br...
Bitcoin tumbled to fresh weekly lows as on-chain metrics show long-term holders under pressure and exchange inflows r...
South Korea’s Kiwoom Securities is nearing a deal to take a minority stake in Bithumb, signaling growing institutiona...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...
Morgan Stanley says the strait hormuz reopening faster is easing supply fears, prompting a downgrade of its oil-price...
SBI Global Asset Management intends to launch Bitcoin and Ethereum ETFs and multi-asset crypto trusts after Japan ref...
A Goldman Sachs strategist warns that leverage is rising across retail investors, hedge funds, and leveraged ETFs, po...